Dow J, Chazal J, Frydman A M, Janny P, Woehrle R, Djebbar F, Gaillot J
J Antimicrob Chemother. 1986 Apr;17 Suppl B:81-7. doi: 10.1093/jac/17.suppl_b.81.
Nine subjects (5 women) aged between 17-66 years, with hydrocephalus were studied. An external ventricular drain was introduced for diagnostic purposes. Cerebro-spinal fluid (CSF) and plasma samples were obtained at suitable intervals after 1 h infusion of 400 mg pefloxacin. In plasma, pefloxacin Cmax was 8.54 +/- 1.53 (mean +/- S.E.M.) mg/l, at the end of infusion, whereas N-desmethyl pefloxacin concentration was 0.17 +/- 0.03 mg/l. The metabolite accounted for only 2% of plasma levels of pefloxacin. In CSF, pefloxacin Cmax was 2.97 +/- 0.32 mg/l, 5-6 h after the start of infusion, whereas N-desmethyl pefloxacin Cmax varied between 0.1-0.2 mg/l. Apart from the 1 h sample, the CSF/plasma ratio of pefloxacin was 60% which is similar to the unbound fraction of pefloxacin in plasma. The apparent half-life (T1/2) of transfer of pefloxacin from plasma to CSF was 1.26 +/- 0.18 h, assuming a first order process, while the apparent elimination T1/2 in CSF was 13.40 +/- 1.76 h, which is similar to the elimination T1/2 found previously in plasma, thus accumulation of pefloxacin in CSF is unlikely. With the present dosage regimen, CSF quickly attains therapeutic levels of pefloxacin.
对9名年龄在17至66岁之间、患有脑积水的受试者(5名女性)进行了研究。为诊断目的插入了外部脑室引流管。在输注400毫克培氟沙星1小时后,于合适的时间间隔采集脑脊液(CSF)和血浆样本。在血浆中,输注结束时培氟沙星的Cmax为8.54±1.53(平均值±标准误)毫克/升,而N-去甲基培氟沙星浓度为0.17±0.03毫克/升。该代谢产物仅占培氟沙星血浆水平的2%。在脑脊液中,输注开始后5至6小时培氟沙星的Cmax为2.97±0.32毫克/升,而N-去甲基培氟沙星的Cmax在0.1至0.2毫克/升之间变化。除了1小时的样本外,培氟沙星的脑脊液/血浆比率为60%,这与培氟沙星在血浆中的游离分数相似。假设为一级过程,培氟沙星从血浆转移到脑脊液的表观半衰期(T1/2)为1.26±0.18小时,而脑脊液中的表观消除半衰期为13.40±1.76小时,这与之前在血浆中发现的消除半衰期相似,因此培氟沙星在脑脊液中不太可能蓄积。按照目前的给药方案,脑脊液能迅速达到培氟沙星的治疗水平。